Pirfenidone Tablets Recalled Due to Manufacturing Compliance Deviations
Accord Healthcare is recalling Pirfenidone 801 mg tablets due to Current Good Manufacturing Practice deviations identified during an FDA inspection. Affected batches P2202519 and P2202513 were distributed in the United States, Puerto Rico, and Canada.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall initiated due to manufacturing facility compliance deviations identified during inspection. No illnesses or injuries have been reported. The recall is precautionary in nature without specific product hazard details.
Plain-English summary
Accord Healthcare, Inc. is recalling Pirfenidone Tablets 801 mg following FDA identification of Current Good Manufacturing Practice (CGMP) deviations during a facility inspection. The recalled batches are P2202519 and P2202513, with an expiration date of 4/30/2024, affecting approximately 2,641 bottles.
The affected product was distributed in the United States, Puerto Rico, and Canada. The manufacturer is Intas Pharmaceuticals Limited in Ahmedabad, India, and the product is distributed by Accord Healthcare, Inc., based in Durham, North Carolina.
Patients currently taking this medication should contact their healthcare provider or pharmacist before taking any action regarding their treatment. Healthcare providers and dispensaries should address inquiries to Accord Healthcare, Inc. or the FDA's drug recall database for additional information.
The recalled product
- Product
- PIRFENIDONE (PIRFENIDONE)
- Brand
- PIRFENIDONE
- Manufacturer
- Accord Healthcare, Inc.
- Hazard
- Affected units
- 2,641
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batches: P2202519
- P2202513 Exp. Date 4/30/2024
UPCs (1)
- 316729468152
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 67 recalled by Accord Healthcare, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 67 products in this recall →Related recalls
Same brand · PIRFENIDONE
- ModeratePirfenidone tablets recalled due to manufacturing process deviations
FDA (Drugs) · 2023-03-08
Same manufacturer · Accord Healthcare, Inc.
See all →- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets
FDA (Drugs) · 2026-09-02
- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateGlimepiride Tablets Recall Due to Manufacturing Quality Deviations
FDA (Drugs) · 2023-04-12
- HighClopidogrel Tablets 75 mg Recalled for Manufacturing Quality Deviations
FDA (Drugs) · 2023-04-12
- ModerateAtorvastatin Calcium Tablets 20 mg Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-04-12
- ModerateGlimepiride Tablets Recalled Due to Manufacturing Process Deviations
FDA (Drugs) · 2023-04-12
- HighSimvastatin Tablets, USP, 80 mg Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2023-04-12
- HighPravastatin Sodium Tablets Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2023-04-12